 |
|
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate
|
|
| Since this article does not have an abstract, we have provided the first 77 words of the full text and any section headings. |
|
|
|
To the Editor: As an intensive care unit director, I read the study by Dr Merten and colleagues with great interest.1 However, as a clinician caring for outpatients, the possibility of oral bicarbonate therapy is important, particularly with its high oral bioavailability. Providing patients with a pre-procedure regimen of bicarbonate pills plus water followed by the same post-procedure treatment may result in efficacy equal to intravenous therapy, leading to a more rapid discharge from the hospital setting.
Robert E. Siegel, MD
robert.siegel@med.va.gov
Critical Care Center
Bronx VA Medical Center
Bronx, NY
1. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328-2334.
FREE FULL TEXT
Letters Section Editor: Robert M. Golub, MD, Senior Editor.
JAMA. 2004;292:1428.
RELATED ARTICLES
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate
L. Shavit, M. Lifschitz, J. Plaksin, and I. N. Slotki
JAMA. 2004;292(12):1428.
EXTRACT
| FULL TEXT
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate—Reply
W. Patrick Burgess, Gregory J. Merten, and Thomas P. Kennedy
JAMA. 2004;292(12):1428-1429.
EXTRACT
| FULL TEXT
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Gregory J. Merten, W. Patrick Burgess, Lee V. Gray, Jeremiah H. Holleman, Timothy S. Roush, Glen J. Kowalchuk, Robert M. Bersin, Arl Van Moore, Charles A. Simonton, III, Robert A. Rittase, H. James Norton, and Thomas P. Kennedy
JAMA. 2004;291(19):2328-2334.
ABSTRACT
| FULL TEXT
|
